|
|
Henderson Morley PLC - Comparative Business Analysis Snapshot
Business Description
Henderson Morley PLC. The Group's principal activity is developing drugs and vaccines for the pharmaceutical industry. Its operation focuses on providing a pipeline of products to the pharmaceutical industry on a worldwide basis. The Group now has 25 granted patents in respect of its ICVT technology platform with a significant number of other patents filed and under examination by the patent authorities. Operations are carried out in Birmingham, England, where it has offices and laboratories.
Competitor Analysis
This analysis compares Henderson Morley PLC with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
